We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current RMD market cap is 32.11B. The company's latest EPS is USD 6.1021 and P/E is 35.77.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.12B | 1.12B | 1.1B | 1.16B | 1.2B |
| Operating Income | 300.49M | 273.04M | 285.1M | 275.83M | 377.43M |
| Net Income | 232.5M | 229.66M | 219.42M | 208.8M | 300.49M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.61B | 2.96B | 3.2B | 3.58B | 4.22B |
| Operating Income | 563.43M | 784.6M | 892.47M | 991.8M | 1.12B |
| Net Income | 404.59M | 621.67M | 474.51M | 779.44M | 897.56M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.71B | 6.75B | 6.74B | 6.91B | 6.81B |
| Total Liabilities | 2.78B | 2.62B | 2.49B | 2.42B | 2.18B |
| Total Equity | 3.93B | 4.13B | 4.25B | 4.48B | 4.63B |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.11B | 4.59B | 4.73B | 5.1B | 6.75B |
| Total Liabilities | 2.04B | 2.09B | 1.84B | 1.74B | 2.62B |
| Total Equity | 2.07B | 2.5B | 2.89B | 3.36B | 4.13B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 455.86M | 693.3M | 286.28M | 559.12M | 961.15M |
| Investing | -1.11B | -1.16B | -148.98M | -190.12M | -223.28M |
| Financing | 611.47M | 422.87M | -151.13M | -390.09M | -726M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 459.05M | 802.26M | 736.72M | 351.15M | 693.3M |
| Investing | -1.08B | -179.86M | -158.46M | -229.92M | -1.16B |
| Financing | 580.64M | -317.29M | -764.63M | -128.36M | 422.87M |
| Market Cap | 32.11B |
| Price to Earnings Ratio | 35.77 |
| Price to Sales Ratio | 7.6 |
| Price to Cash Ratio | 140.89 |
| Price to Book Ratio | 7.77 |
| Dividend Yield | 0.86% |
| Shares Outstanding | 147.09M |
| Average Volume (1 week) | 594.79k |
| Average Volume (1 Month) | 1.12M |
| 52 Week Change | -2.40% |
| 52 Week High | 229.97 |
| 52 Week Low | 132.24 |
| Spread (Intraday) | 24.77 (10.82%) |
| Company Name | ResMed Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.resmed.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
